Health and wellness refers to the state of being in good physical, mental, and emotional health. It encompasses a wide range of factors, including diet, exercise, sleep, stress management, and social support. Maintaining good health and wellness is important for overall well-being and quality of life. It can help to prevent chronic diseases, such as heart disease, diabetes, and cancer, and can improve mental health and cognitive function. According to the latest research, the health and wellness market in China is poised to grow by USD 1.0 trillion during 2023-2029, progressing at a CAGR of 8.96% during the forecast period.
This industry report offers market estimates of the China market, followed by a detailed analysis of the type. The China market data on health and wellness can be segmented by type: consumer healthcare, healthcare infrastructure, healthcare services, non-pharmaceutical products.
The China health and wellness market is highly competitive. The prominent players operating in the China health and wellness market include Ikang Healthcare Group Inc., Jiangsu Hengrui Medicine Co. Ltd., Meinian Onehealth Healthcare Holdings Co. Ltd., Ping An Health Insurance Company of China Ltd., Shanghai Pharmaceuticals Holding Co. Ltd., Sino Biopharmaceutical Limited, Yunnan Baiyao Group Co. Ltd.
The data-centric report focuses on market trends, status and outlook for segments. With comprehensive coverage of the market across different market segments, the report is a valuable asset for the existing players, new entrants and the future investors.
Why buy this report?
▹ Get a detailed picture of the China Health and Wellness Market
▹ Identify segments/areas to invest in over the forecast period in the China Health and Wellness Market
▹ Understand the competitive environment, the market’s leading players
▹ The market estimate for ease of analysis across scenarios in Excel format.
▹ Strategy consulting and research support for three months.
▹ Print authentication provided for the single-user license.
| REPORT ATTRIBUTE | DETAILS |
|---|---|
| Base Year | 2022 |
| Forecast Year | 2023-2029 |
| CAGR (2023-2029) | 8.96% |
| Pages | 18 |
| Key Players | Ikang Healthcare Group Inc., Jiangsu Hengrui Medicine Co. Ltd., Meinian Onehealth Healthcare Holdings Co. Ltd., Ping An Health Insurance Company of China Ltd., Shanghai Pharmaceuticals Holding Co. Ltd., Sino Biopharmaceutical Limited, Yunnan Baiyao Group Co. Ltd. |
The global biopsy devices market is estimated to increase at the rate of 8.3% each year in the period from 2023 to 2029. The top market companies profiles included in…
China antibiotics for multidrug-resistant gram-positive bacteria market by type (daptomycin, linezolid, teicoplanin, tigecycline), by route of administration (injectable, oral), industry snapshot, 2023-2029
China ulcerative colitis (UC) market by type (mild ulcerative colitis, moderate to severe ulcerative colitis), by product (infliximab, mesalazine, sulfasalazine (SSZ), others), industry snapshot, 2023-2029
Please fill out our form and we will get back to you.
